Noninvasive detection of carboxypeptidase G2 activity in vivo

The pseudomonad protein, carboxypeptidase G2 (CPG2), is a prodrug‐activating enzyme utilized in the targeted chemotherapy strategies of antibody‐ and gene‐directed enzyme prodrug therapy (ADEPT and GDEPT). We have developed a noninvasive imaging approach to monitor CPG2 activity in vivo that will facilitate the preclinical and clinical development of CPG2‐based ADEPT and GDEPT strategies. Cleavage of the novel reporter probe, 3,5‐difluorobenzoyl‐L‐glutamic acid (3,5‐DFBGlu), by CPG2, in human colon adenocarcinoma WiDr xenografts engineered to stably express CPG2, was monitored using 19F MRSI. The high signal‐to‐noise ratio afforded by the two MR‐equivalent 19F nuclei of 3,5‐DFBGlu, and the 1.4 ppm 19F chemical shift difference on CPG2‐mediated cleavage, enabled the dynamics and quantification of the apparent pharmacokinetics of 3,5‐DFBGlu and its CPG2‐mediated cleavage in the tumor to be evaluated. In addition, the apparent rate of increase of 3,5‐difluorobenzoic acid concentration could also provide a biomarker of CPG2 activity levels in tumors of patients undergoing CPG2‐based therapies, as well as a biomarker of treatment response. The addition of in vivo reporter probes, such as 3,5‐DFBGlu, to the armamentarium of prodrugs cleaved by CPG2 affords new applications for CPG2 as a gene reporter of transgene expression. Copyright © 2010 John Wiley & Sons, Ltd.

[1]  L. Mancini,et al.  A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy , 2009, NMR in biomedicine.

[2]  Panos Lehouritis,et al.  Attenuated Salmonella Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy , 2008, Clinical Cancer Research.

[3]  R. Blasberg,et al.  Imaging transgene activity in vivo. , 2008, Cancer research.

[4]  C. Springer,et al.  Carboxypeptidase G2-based gene-directed enzyme–prodrug therapy: a new weapon in the GDEPT armoury , 2007, Nature Reviews Cancer.

[5]  T. Scheenen,et al.  Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver , 2007, NMR in biomedicine.

[6]  R. Mason,et al.  19F‐NMR detection of lacZ gene expression via the enzymic hydrolysis of 2‐fluoro‐4‐nitrophenyl β‐D‐galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse 1 , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  C. Springer,et al.  Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. , 2007, Cancer research.

[8]  E. L. Carter,et al.  Escherichia coli abg Genes Enable Uptake and Cleavage of the Folate Catabolite p-Aminobenzoyl-Glutamate , 2007, Journal of bacteriology.

[9]  K. Chester,et al.  A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug , 2006, Clinical Cancer Research.

[10]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[11]  V. Chan,et al.  Enzymatic activity of Campylobacter jejuni hippurate hydrolase. , 2006, Protein engineering, design & selection : PEDS.

[12]  C. Springer,et al.  Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2. , 2005, Cancer research.

[13]  R. Marais,et al.  Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments. , 2004, Methods in molecular medicine.

[14]  C. Springer,et al.  Design of prodrugs for suicide gene therapy. , 2004, Methods in molecular medicine.

[15]  S. Williams,et al.  A comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopy , 2002, NMR in biomedicine.

[16]  R. Ellis.  Macromolecular crowding : obvious but underappreciated , 2022 .

[17]  A. Minton,et al.  The Influence of Macromolecular Crowding and Macromolecular Confinement on Biochemical Reactions in Physiological Media* , 2001, The Journal of Biological Chemistry.

[18]  C. Springer,et al.  In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug , 2000, Cancer Gene Therapy.

[19]  W Wolf,et al.  19F-MRS studies of fluorinated drugs in humans. , 2000, Advanced drug delivery reviews.

[20]  C. Springer,et al.  Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  K. Igarashi,et al.  Difference of the liver and kidney in glycine conjugation of ortho-substituted benzoic acids. , 2000, Chemico-biological interactions.

[22]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Springer,et al.  Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. , 1999, Cancer research.

[24]  D Artemov,et al.  Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging. , 1998, Cancer research.

[25]  D. Brewster,et al.  Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.

[26]  N. J. McNally,et al.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.

[27]  C. Springer,et al.  A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy , 1997, Nature Biotechnology.

[28]  P. Brick,et al.  Crystal structure of carboxypeptidase G2, a bacterial enzyme with applications in cancer therapy. , 1997, Structure.

[29]  C. Presant,et al.  Association of intratumoral pharmacokinetics of fluorouracil with clinical response , 1994, The Lancet.

[30]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[31]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[32]  V. Oliverio,et al.  Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid. , 1972, Biochemical pharmacology.

[33]  P. B. Wood,et al.  The fate of certain organic acids and amides in the rabbit. 12. Aminohydroxybenzoic acids. , 1951, The Biochemical journal.

[34]  P. B. Wood,et al.  The fate of certain organic acids and amides in the rabbit; nitrobenzoic acids and amides. , 1949, The Biochemical journal.

[35]  H. G. Bray,et al.  The fate of certain organic acids and amides in the rabbit: 1. Benzoic and phenylacetic acids and their amides. , 1946, The Biochemical journal.

[36]  J. L. Brakefield.  DETOXICATION OF BENZOIC ACID IN MAN , 1927 .